Health Care·Health Care Equipment·$107.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.29 | N/A | +1.43% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.29 | N/A | +1.43% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on their product developments. However, they did not provide specific guidance for future quarters.
Management expressed confidence in the company's ongoing product pipeline.
They highlighted the importance of innovation in driving future growth.
Medtronic's earnings report showed a slight beat on EPS, which led to a modest increase in stock price. The lack of revenue data and guidance may leave investors cautious. The positive sentiment from management about innovation suggests potential for future growth, but uncertainty remains without specific forecasts.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CADENCE DESIGN SYS I
Feb 19, 2019